Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

English (EN)·Polski (PL)·Ukraiński (UK)
Przejdź do strony domowej biblioteki Uniwersytet Ekonomiczny we Wrocławiu Link otwiera się w nowym oknie Logo biblioteki Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""Alemtuzumab"" wg kryterium: Temat

  Lista filtrów
Wyrównaj
Wyświetlanie 1-20 z 6077
Tytuł:
The role of graft T-cell size in patients receiving alemtuzumab serotherapy for non-malignant disorders: results of an institutional protocol.
Autorzy:
Pandrowala, Ambreen (AUTHOR)
Khan, Sanna (AUTHOR)
Kataria, Darshan (AUTHOR)
Kakunje, Manasa (AUTHOR)
Mishra, Varsha (AUTHOR)
Mamtora, Dhruv (AUTHOR)
Mudaliar, Sangeeta (AUTHOR)
Bodhanwala, Minnie (AUTHOR)
Agarwal, Bharat (AUTHOR)
Hiwarkar, Prashant (AUTHOR)
Pokaż więcej
Źródło:
Scientific Reports. 2/15/2024, Vol. 14 Issue 1, p1-8. 8p.
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Long-Smoldering T-prolymphocytic Leukemia: A Case Report and a Review of the Literature.
Autorzy:
Gjelberg HK; Department of Pathology, Haukeland University Hospital, N-5021 Bergen, Norway.
Helgeland L; Department of Pathology, Haukeland University Hospital, N-5021 Bergen, Norway.; Department of Clinical Science, University of Bergen, N-5021 Bergen, Norway.
Liseth K; Department of Immunology and Transfusion Medicine, Haukeland University Hospital, N-5021 Bergen, Norway.
Micci F; Section for Cancer Cytogenetics, Institute of Cancer Genetics and Informatics, Oslo University Hospital, N-0424 Oslo, Norway.
Sandnes M; Department of Medicine, Haukeland University Hospital, N-5021 Bergen, Norway.
Russnes HG; Department of Pathology, Oslo University Hospital, N-0424 Oslo, Norway.; Department of Cancer Genetics, Institute for Cancer Research, Oslo University Hospital, N-0424 Oslo, Norway.; Institute for Clinical Medicine, Faculty of Medicine, University of Oslo, N-0424 Oslo, Norway.
Reikvam H; Department of Medicine, Haukeland University Hospital, N-5021 Bergen, Norway.; Department of Medical Science, University of Bergen, N-5021 Bergen, Norway.
Pokaż więcej
Źródło:
Current oncology (Toronto, Ont.) [Curr Oncol] 2023 Nov 18; Vol. 30 (11), pp. 10007-10018. Date of Electronic Publication: 2023 Nov 18.
Typ publikacji:
Review; Case Reports
MeSH Terms:
Leukemia, Prolymphocytic*/diagnosis
Leukemia, Prolymphocytic*/genetics
Leukemia, Prolymphocytic*/therapy
Leukemia, Prolymphocytic, T-Cell*/diagnosis
Leukemia, Prolymphocytic, T-Cell*/genetics
Leukemia, Prolymphocytic, T-Cell*/therapy
Humans ; Alemtuzumab/therapeutic use
Recenzja
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Transcriptome alterations in peripheral blood B cells of patients with multiple sclerosis receiving immune reconstitution therapy.
Autorzy:
Hecker M; Division of Neuroimmunology, Department of Neurology, Rostock University Medical Center, Gehlsheimer Str. 20, 18147, Rostock, Germany. .
Fitzner B; Division of Neuroimmunology, Department of Neurology, Rostock University Medical Center, Gehlsheimer Str. 20, 18147, Rostock, Germany.
Boxberger N; Division of Neuroimmunology, Department of Neurology, Rostock University Medical Center, Gehlsheimer Str. 20, 18147, Rostock, Germany.
Putscher E; Division of Neuroimmunology, Department of Neurology, Rostock University Medical Center, Gehlsheimer Str. 20, 18147, Rostock, Germany.
Engelmann R; Clinic III (Hematology, Oncology and Palliative Medicine), Special Hematology Laboratory, Rostock University Medical Center, Ernst-Heydemann-Str. 6, 18057, Rostock, Germany.
Bergmann W; Core Facility for Cell Sorting and Cell Analysis, Rostock University Medical Center, Schillingallee 70, 18057, Rostock, Germany.
Müller M; Core Facility for Cell Sorting and Cell Analysis, Rostock University Medical Center, Schillingallee 70, 18057, Rostock, Germany.
Ludwig-Portugall I; Miltenyi Biotec B.V. & Co. KG, Robert-Koch-Str. 1, 17166, Teterow, Germany.
Schwartz M; Division of Neuroimmunology, Department of Neurology, Rostock University Medical Center, Gehlsheimer Str. 20, 18147, Rostock, Germany.
Meister S; Division of Neuroimmunology, Department of Neurology, Rostock University Medical Center, Gehlsheimer Str. 20, 18147, Rostock, Germany.
Dudesek A; Division of Neuroimmunology, Department of Neurology, Rostock University Medical Center, Gehlsheimer Str. 20, 18147, Rostock, Germany.
Winkelmann A; Division of Neuroimmunology, Department of Neurology, Rostock University Medical Center, Gehlsheimer Str. 20, 18147, Rostock, Germany.
Koczan D; Institute of Immunology, Rostock University Medical Center, Schillingallee 70, 18057, Rostock, Germany.
Zettl UK; Division of Neuroimmunology, Department of Neurology, Rostock University Medical Center, Gehlsheimer Str. 20, 18147, Rostock, Germany.
Pokaż więcej
Źródło:
Journal of neuroinflammation [J Neuroinflammation] 2023 Aug 02; Vol. 20 (1), pp. 181. Date of Electronic Publication: 2023 Aug 02.
Typ publikacji:
Journal Article
MeSH Terms:
Multiple Sclerosis*
Immune Reconstitution*
Neurodegenerative Diseases*/chemically induced
Multiple Sclerosis, Relapsing-Remitting*/drug therapy
Multiple Sclerosis, Relapsing-Remitting*/genetics
Humans ; Cladribine/adverse effects ; Transcriptome ; Alemtuzumab/therapeutic use ; RNA-Binding Proteins ; Ubiquitin-Protein Ligases
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
T-Cell Prolymphocytic Leukemia: Diagnosis, Pathogenesis, and Treatment.
Autorzy:
Gutierrez M; Department of Internal Medicine, University of Michigan, Ann Arbor, MI 48109, USA.
Bladek P; Department of Pathology, University of Illinois Chicago, Chicago, IL 60607, USA.
Goksu B; Department of Pathology, University of Illinois Chicago, Chicago, IL 60607, USA.
Murga-Zamalloa C; Department of Pathology, University of Illinois Chicago, Chicago, IL 60607, USA.
Bixby D; Department of Internal Medicine, Division of Hematology and Oncology, University of Michigan, Ann Arbor, MI 60607, USA.
Wilcox R; Department of Internal Medicine, Division of Hematology and Oncology, University of Michigan, Ann Arbor, MI 60607, USA.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2023 Jul 28; Vol. 24 (15). Date of Electronic Publication: 2023 Jul 28.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Leukemia, Prolymphocytic, T-Cell*/etiology
Leukemia, Prolymphocytic, T-Cell*/genetics
Hematopoietic Stem Cell Transplantation*
Humans ; Alemtuzumab/therapeutic use ; Mutation
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
aHSCT is superior to alemtuzumab in maintaining NEDA and improving cognition in multiple sclerosis.
Autorzy:
Häußler V; Institute of Neuroimmunology and Multiple Sclerosis, University Medical Centre Hamburg-Eppendorf, Falkenried 94, Hamburg, 20251, Germany.; Department of Neurology, University Medical Centre Hamburg-Eppendorf, Martinistraße 52, Hamburg, 20246, Germany.
Ufer F; Institute of Neuroimmunology and Multiple Sclerosis, University Medical Centre Hamburg-Eppendorf, Falkenried 94, Hamburg, 20251, Germany.; Department of Neurology, University Medical Centre Hamburg-Eppendorf, Martinistraße 52, Hamburg, 20246, Germany.
Pöttgen J; Institute of Neuroimmunology and Multiple Sclerosis, University Medical Centre Hamburg-Eppendorf, Falkenried 94, Hamburg, 20251, Germany.; Department of Neurology, University Medical Centre Hamburg-Eppendorf, Martinistraße 52, Hamburg, 20246, Germany.
Wolschke C; Department of Stem Cell Transplantation, University Medical Center Hamburg-Eppendorf, Martinistraße 52, Hamburg, 20246, Germany.
Friese MA; Institute of Neuroimmunology and Multiple Sclerosis, University Medical Centre Hamburg-Eppendorf, Falkenried 94, Hamburg, 20251, Germany.; Department of Neurology, University Medical Centre Hamburg-Eppendorf, Martinistraße 52, Hamburg, 20246, Germany.
Kröger N; Department of Stem Cell Transplantation, University Medical Center Hamburg-Eppendorf, Martinistraße 52, Hamburg, 20246, Germany.
Heesen C; Institute of Neuroimmunology and Multiple Sclerosis, University Medical Centre Hamburg-Eppendorf, Falkenried 94, Hamburg, 20251, Germany.; Department of Neurology, University Medical Centre Hamburg-Eppendorf, Martinistraße 52, Hamburg, 20246, Germany.
Stellmann JP; Institute of Neuroimmunology and Multiple Sclerosis, University Medical Centre Hamburg-Eppendorf, Falkenried 94, Hamburg, 20251, Germany.; Department of Neurology, University Medical Centre Hamburg-Eppendorf, Martinistraße 52, Hamburg, 20246, Germany.; APHM, Hopital de la Timone, CEMEREM, Marseille, France.; Aix Marseille Univ, CNRS, CRMBM, UMR 7339, Marseille, France.
Pokaż więcej
Źródło:
Annals of clinical and translational neurology [Ann Clin Transl Neurol] 2021 Jun; Vol. 8 (6), pp. 1269-1278. Date of Electronic Publication: 2021 May 05.
Typ publikacji:
Comparative Study; Journal Article
MeSH Terms:
Disease Progression*
Hematopoietic Stem Cell Transplantation*
Registries*
Alemtuzumab/*pharmacology
Cognitive Dysfunction/*therapy
Multiple Sclerosis/*diagnosis
Multiple Sclerosis/*therapy
Adult ; Alemtuzumab/administration & dosage ; Cognitive Dysfunction/drug therapy ; Cognitive Dysfunction/etiology ; Female ; Follow-Up Studies ; Humans ; Magnetic Resonance Imaging ; Male ; Middle Aged ; Multiple Sclerosis/complications ; Multiple Sclerosis/drug therapy ; Neuropsychological Tests ; Outcome Assessment, Health Care ; Patient Acuity ; Transplantation, Autologous ; Young Adult
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Targeted Large-Volume Lymphocyte Removal Using Magnetic Nanoparticles in Blood Samples of Patients with Chronic Lymphocytic Leukemia: A Proof-of-Concept Study.
Autorzy:
Janker, Stefanie (AUTHOR)
Doswald, Simon (AUTHOR)
Schimmer, Roman R. (AUTHOR)
Schanz, Urs (AUTHOR)
Stark, Wendelin J. (AUTHOR)
Schläpfer, Martin (AUTHOR)
Beck-Schimmer, Beatrice (AUTHOR)
Pokaż więcej
Źródło:
International Journal of Molecular Sciences. Apr2023, Vol. 24 Issue 8, p7523. 11p.
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Short-term response to alemtuzumab in CD52-positive secondary histiocytic sarcoma in a child: Is it time to consider new targets?
Autorzy:
Valera ET; Department of Pediatrics, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, Brazil.
Brassesco MS; Department of Biology, Faculty of Philosophy, Sciences and Letters at Ribeirão Preto, University of São Paulo, Brazil.
Reis MBFD; Department of Pediatrics, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, Brazil.
Maggioni G; Laboratório Dr. Prates, Ribeirão Preto, Brazil.
Guerino-Cunha RL; Bone Marrow Transplantation and Cellular Therapy Unit, Department of Medical Imaging, Hematology and Clinical Oncology, Ribeirão Preto Medical School, University of São Paulo Brazil.
Grecco CE; Bone Marrow Transplantation and Cellular Therapy Unit, Department of Medical Imaging, Hematology and Clinical Oncology, Ribeirão Preto Medical School, University of São Paulo Brazil.
Jr JE; Department of Medical Imaging, Hematology and Clinical Oncology, Ribeirão Preto Medical School, University of São Paulo Brazil.
Kato M; Diagnostic of Nuclear Medicine - DIMEN - Ribeirão Preto, Brazil.
Tone LG; Department of Pediatrics, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, Brazil.
Pokaż więcej
Źródło:
Pediatric hematology and oncology [Pediatr Hematol Oncol] 2021 Feb; Vol. 38 (1), pp. 89-96. Date of Electronic Publication: 2020 Sep 08.
Typ publikacji:
Case Reports; Letter
MeSH Terms:
Alemtuzumab/*therapeutic use
Histiocytic Sarcoma/*drug therapy
Alemtuzumab/pharmacology ; Child ; Humans ; Male
Raport
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Real-World Retrospective Analysis of Alemtuzumab Outcomes in Relapsing-Remitting Multiple Sclerosis: The LEMCAM Study.
Autorzy:
Costa-Frossard França, Lucienne (AUTHOR)
Meca Lallana, Virginia (AUTHOR)
Labiano-Fontcuberta, Andrés (AUTHOR)
Blasco, Rosario (AUTHOR)
Monreal, Enric (AUTHOR)
Martínez Ginés, María Luisa (AUTHOR)
Aguirre, Clara (AUTHOR)
Sabin Muñoz, Julia (AUTHOR)
Sainz de la Maza, Susana (AUTHOR)
Cuello, Juan Pablo (AUTHOR)
Díaz-Pérez, Carolina (AUTHOR)
Chico García, Juan Luis (AUTHOR)
Lozano Ros, Alberto (AUTHOR)
Rodríguez Jorge, Fernando (AUTHOR)
Martínez Martínez, Susana (AUTHOR)
García Domínguez, José Manuel (AUTHOR)
Pokaż więcej
Źródło:
CNS Drugs. Mar2024, Vol. 38 Issue 3, p231-238. 8p.
Czasopismo naukowe
Szczegóły
Tytuł:
Corrigendum: Real-World Treatment Patterns of Antiviral Prophylaxis for Cytomegalovirus Among Adult Kidney Transplant Recipients: A Linked USRDS-Medicare Database Study.
Źródło:
Transplant International. 2024, p1-10. 10p.
Czasopismo naukowe
Szczegóły
Tytuł:
Alemtuzumab versus anti‐thymocyte globulin in kidney transplant recipients receiving a rapid steroid withdrawal regimen.
Autorzy:
Rikard, Rachel A. (AUTHOR)
Chargualaf, Laura M. (AUTHOR)
Coulter, Carolyn (AUTHOR)
Weimer, Eric T. (AUTHOR)
Schmitz, John L. (AUTHOR)
Kotzen, Elizabeth S. (AUTHOR)
Prom, Alyson (AUTHOR)
Toledo, Alexander H. (AUTHOR)
Szempruch, Kristen R. (AUTHOR)
Pokaż więcej
Źródło:
Clinical Transplantation. Feb2024, Vol. 38 Issue 2, p1-7. 7p.
Czasopismo naukowe
Szczegóły
Tytuł:
Mutations in PIGA cause a CD52-/GPI-anchor-deficient phenotype complicating alemtuzumab treatment in T-cell prolymphocytic leukemia.
Autorzy:
Johansson P; Department of Hematology, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.
Klein-Hitpass L; Institute of Cell Biology (Cancer Research), University Hospital Essen, University of Duisburg-Essen, Essen, Germany.
Röth A; Department of Hematology, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.
Möllmann M; Department of Hematology, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.
Reinhardt HC; Department of Hematology, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.; German Consortium for Translational Cancer Research (DKTK), Heidelberg, Germany.
Dührsen U; Department of Hematology, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.
Dürig J; Department of Hematology, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.; German Consortium for Translational Cancer Research (DKTK), Heidelberg, Germany.; Department of General Internal Medicine, St. Josef-Krankenhaus, Medical Faculty, University of Duisburg-Essen, Essen, Germany.
Pokaż więcej
Źródło:
European journal of haematology [Eur J Haematol] 2020 Dec; Vol. 105 (6), pp. 786-796. Date of Electronic Publication: 2020 Sep 28.
Typ publikacji:
Journal Article
MeSH Terms:
Mutation*
Alemtuzumab/*pharmacology
CD52 Antigen/*genetics
Leukemia, Prolymphocytic, T-Cell/*genetics
Membrane Proteins/*genetics
T-Lymphocytes/*drug effects
T-Lymphocytes/*metabolism
Alemtuzumab/therapeutic use ; CD52 Antigen/metabolism ; DNA Mutational Analysis ; Gene Expression Regulation, Leukemic/drug effects ; High-Throughput Nucleotide Sequencing ; Humans ; Immunophenotyping ; Leukemia, Prolymphocytic, T-Cell/drug therapy ; Leukemia, Prolymphocytic, T-Cell/metabolism ; Membrane Proteins/metabolism ; Phenotype ; T-Lymphocytes/pathology
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Alemtuzumab and autoimmune haemolytic anaemia: Coincidence or causation?
Autorzy:
Jacobs JW; Department of Laboratory Medicine, Yale School of Medicine, New Haven, Connecticut, USA.
Adkins BD; Department of Pathology, Division of Transfusion Medicine and Hemostasis, University of Texas Southwestern, Dallas, Texas, USA.
Woo JS; Department of Pathology, City of Hope National Medical Center, Irvine, California, USA.
Stephens LD; Department of Pathology, University of California San Diego, La Jolla, California, USA.
Booth GS; Department of Pathology, Microbiology and Immunology, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
Pokaż więcej
Źródło:
Vox sanguinis [Vox Sang] 2023 Apr; Vol. 118 (4), pp. 257-259. Date of Electronic Publication: 2023 Jan 22.
Typ publikacji:
Journal Article
MeSH Terms:
Anemia, Hemolytic, Autoimmune*
Humans ; Alemtuzumab/adverse effects
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Acquired haemophilia A after alemtuzumab therapy.
Autorzy:
van der Zwan M; Department of Internal Medicine, Division of Nephrology and Transplantation, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands.; Rotterdam Transplant Group, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands.
Leebeek FWG; Department of Hematology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands.
Sandberg Y; Department of Internal Medicine, Maasstad Hospital Rotterdam, Rotterdam, The Netherlands.
Kruip MJHA; Department of Hematology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands.
Hesselink DA; Department of Internal Medicine, Division of Nephrology and Transplantation, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands.; Rotterdam Transplant Group, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands.
Pokaż więcej
Źródło:
Haemophilia : the official journal of the World Federation of Hemophilia [Haemophilia] 2020 Nov; Vol. 26 (6), pp. e337-e339. Date of Electronic Publication: 2020 Jul 22.
Typ publikacji:
Letter
MeSH Terms:
Alemtuzumab/*therapeutic use
Antineoplastic Agents, Immunological/*therapeutic use
Hemophilia A/*drug therapy
Adult ; Alemtuzumab/pharmacology ; Antineoplastic Agents, Immunological/pharmacology ; Humans ; Male ; Young Adult
Opinia redakcyjna
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Haploidentical Stem Cell Transplantation Using Post-Transplant Cyclophosphamide for T-Cell Prolymphocytic Leukemia after Alemtuzumab Induction Therapy: A Case Report.
Autorzy:
Okada, Naoki (AUTHOR)
Yamamoto, Ryusuke (AUTHOR)
Maruoka, Hayato (AUTHOR)
Himeno, Mayuko (AUTHOR)
Hiramoto, Nobuhiro (AUTHOR)
Ishikawa, Takayuki (AUTHOR)
Pokaż więcej
Źródło:
Case Reports in Oncology. 2023, Vol. 16 Issue 1, p604-612. 9p.
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Adverse events with fatal outcome associated with alemtuzumab treatment in multiple sclerosis.
Autorzy:
Holmøy T; Department of Neurology, Akershus University Hospital, Post Office Box 1000, 1478, Lørenskog, Norway. .; Institute of Clinical Medicine, University of Oslo, Oslo, Norway. .
Fevang B; Centre for Rare Disorders, Oslo University Hospital, Sognsvannsveien 20, 0372, Oslo, Norway.; Section of Clinical Immunology and Infectious Diseases, Oslo University Hospital, Sognsvannsveien 20, 0372, Oslo, Norway.
Olsen DB; Department of Pharmacovigilance, Norwegian Medicines Agency, Post Office Box 240, Skøyen, 0213, Oslo, Norway.
Spigset O; Department of Clinical Pharmacology, St. Olavs University Hospital, Post Office Box 3250, Torgarden, 7006, Trondheim, Norway.; Department of Clinical and Molecular Medicine, Norwegian University of Science and Technology, Trondheim, Norway.
Bø L; Norwegian Multiple Sclerosis Competence Centre, Department of Neurology, Haukeland University Hospital, Post Office Box 1400, 5021, Bergen, Norway.; Department of Clinical Medicine, University of Bergen, Bergen, Norway.
Pokaż więcej
Źródło:
BMC research notes [BMC Res Notes] 2019 Aug 12; Vol. 12 (1), pp. 497. Date of Electronic Publication: 2019 Aug 12.
Typ publikacji:
Case Reports; Journal Article; Systematic Review
MeSH Terms:
Agranulocytosis/*chemically induced
Alemtuzumab/*adverse effects
Cerebral Hemorrhage/*chemically induced
Immunologic Factors/*adverse effects
Listeriosis/*chemically induced
Multiple Organ Failure/*chemically induced
Multiple Sclerosis, Relapsing-Remitting/*drug therapy
Pneumonia/*chemically induced
Adult ; Agranulocytosis/mortality ; Agranulocytosis/pathology ; Alemtuzumab/administration & dosage ; Cerebral Hemorrhage/mortality ; Cerebral Hemorrhage/pathology ; Fatal Outcome ; Female ; Humans ; Immunologic Factors/administration & dosage ; Listeriosis/microbiology ; Listeriosis/mortality ; Listeriosis/pathology ; Male ; Middle Aged ; Multiple Organ Failure/mortality ; Multiple Organ Failure/pathology ; Multiple Sclerosis, Relapsing-Remitting/pathology ; Pneumonia/microbiology ; Pneumonia/mortality ; Pneumonia/pathology
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Induction therapy in lung transplantation: A contemporary analysis of trends and outcomes.
Autorzy:
Shagabayeva L; DeWitt Daughtry Family Department of Surgery, University of Miami Health System, Miami, Florida, USA.
Osho AA; Division of Cardiac Surgery, Department of Surgery, Massachusetts General Hospital, Boston, Massachusetts, USA.
Moonsamy P; Division of Cardiac Surgery, Department of Surgery, Massachusetts General Hospital, Boston, Massachusetts, USA.
Mohan N; Division of Cardiac Surgery, Department of Surgery, Massachusetts General Hospital, Boston, Massachusetts, USA.
Li SS; Division of Cardiac Surgery, Department of Surgery, Massachusetts General Hospital, Boston, Massachusetts, USA.
Wolfe S; Division of Cardiac Surgery, Department of Surgery, Massachusetts General Hospital, Boston, Massachusetts, USA.
Langer NB; Division of Cardiac Surgery, Department of Surgery, Massachusetts General Hospital, Boston, Massachusetts, USA.
Funamoto M; Department of Cardiothoracic Surgery, Methodist Hospital, San Antonio, Texas, USA.
Villavicencio MA; Department of Cardiovascular Surgery, Mayo Clinic, Rochester, Minnesota, USA.
Pokaż więcej
Źródło:
Clinical transplantation [Clin Transplant] 2022 Nov; Vol. 36 (11), pp. e14782. Date of Electronic Publication: 2022 Jul 30.
Typ publikacji:
Review; Journal Article
MeSH Terms:
Lung Transplantation*
Renal Insufficiency*
Adult ; Humans ; Antilymphocyte Serum/adverse effects ; Immunosuppressive Agents/adverse effects ; Graft Rejection/drug therapy ; Graft Rejection/etiology ; Antibodies, Monoclonal/therapeutic use ; Basiliximab/therapeutic use ; Alemtuzumab/therapeutic use ; Recombinant Fusion Proteins/therapeutic use
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Ella versus Simoa Serum Neurofilament Assessment to Monitor Treatment Response in Highly Active Multiple Sclerosis Patients.
Autorzy:
Nötzel M; Department of Neurology, Technische Universität Dresden, 01307 Dresden, Germany.
Werder LI; Department of Neurology, Technische Universität Dresden, 01307 Dresden, Germany.
Ziemssen T; Department of Neurology, Technische Universität Dresden, 01307 Dresden, Germany.
Akgün K; Department of Neurology, Technische Universität Dresden, 01307 Dresden, Germany.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2022 Oct 15; Vol. 23 (20). Date of Electronic Publication: 2022 Oct 15.
Typ publikacji:
Journal Article
MeSH Terms:
Multiple Sclerosis*/drug therapy
Humans ; Intermediate Filaments ; Alemtuzumab ; Neurofilament Proteins ; Biomarkers ; Monitoring, Physiologic
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Wyświetlanie 1-20 z 6077

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies